Cargando…

Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain

Alzheimer’s disease (AD) neuropathologic change is characterized by amyloid plaques and neurofibrillary tangles (NFTs) that consist of aggregated amyloid beta (Abeta) and hyperphosphorylated tau proteins (p-tau), respectively. Although the global relationship between Abeta and p-tau has been studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Horie, Kanta, Barthélemy, Nicolas R., Mallipeddi, Nipun, Li, Yan, Franklin, Erin E., Perrin, Richard J., Bateman, Randall J., Sato, Chihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450927/
https://www.ncbi.nlm.nih.gov/pubmed/32854776
http://dx.doi.org/10.1186/s40478-020-01019-z
_version_ 1783574887738114048
author Horie, Kanta
Barthélemy, Nicolas R.
Mallipeddi, Nipun
Li, Yan
Franklin, Erin E.
Perrin, Richard J.
Bateman, Randall J.
Sato, Chihiro
author_facet Horie, Kanta
Barthélemy, Nicolas R.
Mallipeddi, Nipun
Li, Yan
Franklin, Erin E.
Perrin, Richard J.
Bateman, Randall J.
Sato, Chihiro
author_sort Horie, Kanta
collection PubMed
description Alzheimer’s disease (AD) neuropathologic change is characterized by amyloid plaques and neurofibrillary tangles (NFTs) that consist of aggregated amyloid beta (Abeta) and hyperphosphorylated tau proteins (p-tau), respectively. Although the global relationship between Abeta and p-tau has been studied for decades, it is still unclear whether a regional correlation exists between Abeta and p-tau in the human brain. Recent studies in cerebrospinal fluid (CSF) have suggested that tau phosphorylation at specific sites such as T217 is modified at an early stage of AD when amyloid plaques become detectable. We applied biochemical and mass spectrometry methods in human brain samples with and without Abeta plaque pathology to measure site-specific phosphorylation occupancies in soluble and insoluble tau. Our quantitative results identified multiple residues specifically hyper-phosphorylated in AD, including at sites T111, T153, S184 (or S185), T205, S208, T217, S262, and S285 in brain soluble tau. In contrast, the most enriched phosphorylated residues in brain insoluble tau were T111, S113, T153, T181, S199, S202, T205, T217, T231, S262, and S396. Tau phosphorylation occupancies in the insoluble fraction were relatively constant across brain regions, suggesting that tau has a consistent phosphorylation pattern once it has aggregated into NFTs. We did not find regional association between Abeta42 and insoluble tau. However, the phosphorylation profile of soluble tau in AD brain was highly correlated to that in AD CSF, which was analyzed in a previous study. We also found a higher regional association between total Abeta42 and soluble tau phosphorylation occupancy at residues T111, T153 and T217 in the brain. This study provides insights into regional interactions between amyloidosis and specific tau phosphorylated residues in the human brain and may explain the specific increases of tau species phosphorylation observed in AD CSF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-020-01019-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7450927
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74509272020-08-28 Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain Horie, Kanta Barthélemy, Nicolas R. Mallipeddi, Nipun Li, Yan Franklin, Erin E. Perrin, Richard J. Bateman, Randall J. Sato, Chihiro Acta Neuropathol Commun Research Alzheimer’s disease (AD) neuropathologic change is characterized by amyloid plaques and neurofibrillary tangles (NFTs) that consist of aggregated amyloid beta (Abeta) and hyperphosphorylated tau proteins (p-tau), respectively. Although the global relationship between Abeta and p-tau has been studied for decades, it is still unclear whether a regional correlation exists between Abeta and p-tau in the human brain. Recent studies in cerebrospinal fluid (CSF) have suggested that tau phosphorylation at specific sites such as T217 is modified at an early stage of AD when amyloid plaques become detectable. We applied biochemical and mass spectrometry methods in human brain samples with and without Abeta plaque pathology to measure site-specific phosphorylation occupancies in soluble and insoluble tau. Our quantitative results identified multiple residues specifically hyper-phosphorylated in AD, including at sites T111, T153, S184 (or S185), T205, S208, T217, S262, and S285 in brain soluble tau. In contrast, the most enriched phosphorylated residues in brain insoluble tau were T111, S113, T153, T181, S199, S202, T205, T217, T231, S262, and S396. Tau phosphorylation occupancies in the insoluble fraction were relatively constant across brain regions, suggesting that tau has a consistent phosphorylation pattern once it has aggregated into NFTs. We did not find regional association between Abeta42 and insoluble tau. However, the phosphorylation profile of soluble tau in AD brain was highly correlated to that in AD CSF, which was analyzed in a previous study. We also found a higher regional association between total Abeta42 and soluble tau phosphorylation occupancy at residues T111, T153 and T217 in the brain. This study provides insights into regional interactions between amyloidosis and specific tau phosphorylated residues in the human brain and may explain the specific increases of tau species phosphorylation observed in AD CSF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-020-01019-z) contains supplementary material, which is available to authorized users. BioMed Central 2020-08-27 /pmc/articles/PMC7450927/ /pubmed/32854776 http://dx.doi.org/10.1186/s40478-020-01019-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Horie, Kanta
Barthélemy, Nicolas R.
Mallipeddi, Nipun
Li, Yan
Franklin, Erin E.
Perrin, Richard J.
Bateman, Randall J.
Sato, Chihiro
Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
title Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
title_full Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
title_fullStr Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
title_full_unstemmed Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
title_short Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
title_sort regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450927/
https://www.ncbi.nlm.nih.gov/pubmed/32854776
http://dx.doi.org/10.1186/s40478-020-01019-z
work_keys_str_mv AT horiekanta regionalcorrelationofbiochemicalmeasuresofamyloidandtauphosphorylationinthebrain
AT barthelemynicolasr regionalcorrelationofbiochemicalmeasuresofamyloidandtauphosphorylationinthebrain
AT mallipeddinipun regionalcorrelationofbiochemicalmeasuresofamyloidandtauphosphorylationinthebrain
AT liyan regionalcorrelationofbiochemicalmeasuresofamyloidandtauphosphorylationinthebrain
AT franklinerine regionalcorrelationofbiochemicalmeasuresofamyloidandtauphosphorylationinthebrain
AT perrinrichardj regionalcorrelationofbiochemicalmeasuresofamyloidandtauphosphorylationinthebrain
AT batemanrandallj regionalcorrelationofbiochemicalmeasuresofamyloidandtauphosphorylationinthebrain
AT satochihiro regionalcorrelationofbiochemicalmeasuresofamyloidandtauphosphorylationinthebrain